Last reviewed · How we verify
Pharmacokinetics and Tolerability of Sulthiame
This preliminary pilot exploration aims at specifying the pharmacokinetic parameters of sulthiame, formulated as an immediate release tablet, thus helping to design proper clinical trials for the future assessment of new paediatric formulations currently under development. The clinical tolerability to single doses of sulthiame will also be closely monitored to orient future trials.
Details
| Lead sponsor | Centre Hospitalier Universitaire Vaudois |
|---|---|
| Phase | PHASE1 |
| Status | COMPLETED |
| Enrolment | 4 |
| Start date | Mon Feb 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Thu Aug 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Epilepsy
Interventions
- Sulthiame
Countries
Switzerland